Article

AJMC® in the Press, January 12, 2018

Author(s):

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Modern Medicine’s article on antibiotic stewardship programs cited a study published in The American Journal of Managed Care® (AJMC®) when discussing the value of the programs. The study, “Improving Antibiotic Stewardship: A Stepped-Wedge Cluster Randomized Trial,” found that using computer alerts to inform doctors when antibiotics may not be the best course of treatment led to a 22% improvement in the odds of prescribing antibiotics. The authors concluded that clinical decision software integrated in an electronic health record can discourage inappropriate antibiotic prescribing and will likely change diagnostic patterns.

Another Modern Medicine article centered on the AJMC®-published article, “The Role of Direct Oral Anticoagulants in the Management of Venous Thromboembolism.” The article reported that, compared with warfarin, direct oral anticoagulants (DOACs) provide a more predictable anticoagulant response, fewer drug interactions, significantly less risk of hemorrhagic stroke, no monitoring requirements, and short half-lives. However, there are many patients for whom DOACs are not suitable. According to the author, patients with liver disease, coagulopathy, severe kidney disease, or cancer should not receive DOACs.

Related Videos
Jawad Haider Butt, MD, PhD
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Andrew Kuykendall, MD, Moffitt Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo